866-997-4948(US-Canada Toll Free)

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals

Published By :

GlobalData

Published Date : Oct 2018

Category :

Pharmaceutical

No. of Pages : 80 Pages

Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals

Summary

GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for May 2018 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2018. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Pharmaceuticals & Healthcare, Global, Deal Summary 10
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, May 2018 10
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, May 2018 12
2.2.1 Takeda Pharma to Raise up to USD20 Billion in Private Placement of Bonds 12
2.2.2 GlaxoSmithKline Raises USD6 Billion in Public Offering of Bonds 12
2.2.3 Eli Lilly Acquires ARMO Biosciences for USD1.6 Billion 12
2.2.4 Janssen Biotech Acquires 76% stake in BeneVir Biopharm 13
2.2.5 Lodo Therapeutics Enters into Agreement with Genentech 13
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, May 2018 14
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, May 2018 15
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 16
3.1 Pharmaceuticals & Healthcare, Global, M&A, May 2018 16
3.1.1 Top M&A Deals in May 2018 17
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, December 2017 - May 2018 18
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, May 2018 19
3.2.1 Top Equity Offering Deals in May 2018 20
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, December 2017 - May 2018 21
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, May 2018 22
3.3.1 Top PE/VC Deals in May 2018 23
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, May 2018 24
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, May 2018 25
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, June 2016-May 2018 27
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, June 2016-May 2018 28
3.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, May 2018 29
3.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, December 2017 - May 2018 30
3.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), May 2018 31
3.6.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, May 2018 32
3.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 33
3.8 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, December 2017 - May 2018 34
3.9 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m),
December 2017 - May 2018 35
3.10 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 36
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2018 38
4.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, May 2018 38
4.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), May 2018 39
4.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), December 2017 - May 2018 40
4.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), December 2017 - May 2018 41
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), December 2017 - May 2018 42
4.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), December 2017 - May 2018 44
4.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, May 2018 45
4.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, May 2018 46
4.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, May 2018 46
5 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 47
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, May 2018 47
5.1.1 Oncology - Deals of the Month 48
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, May 2018 50
5.2.1 Central Nervous System - Deals of the Month 51
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, May 2018 53
5.3.1 Infectious Diseases - Deals of the Month 54
5.4 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, May 2018 56
5.4.1 Cardiovascular - Deal of the Month 57
5.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, May 2018 59
5.5.1 Immunology - Deals of the Month 60
5.6 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, May 2018 62
5.6.1 Gastrointestinal - Deal of the Month 63
5.7 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, May 2018 64
5.7.1 Metabolic Disorders - Deals of the Month 65
6 Deal Summary by Geography 66
6.1 Pharmaceuticals & Healthcare, North America Deals, May 2018 66
6.1.1 North America - Deals of the Month 67
6.2 Pharmaceuticals & Healthcare, Europe, Deals, May 2018 69
6.2.1 Europe - Deals of the Month 70
6.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, May 2018 71
6.3.1 Asia-Pacific - Deals of the Month 72
6.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, May 2018 74
6.4.1 Rest of the World - Deals of the Month 75
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 76
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, December 2017 - May 2018 76
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, December 2017 - May 2018 77
8 Further Information 78
8.1 Methodology 78
8.2 About GlobalData 79
8.3 Contact Us 79
8.4 Disclosure information 79
8.5 Disclaimer 80

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 11
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, May 2018 12
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), May 2018 15
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 17
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, May 2018 17
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, December 2017 - May 2018 18
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 20
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, May 2018 20
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 21
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 23
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, May 2018 23
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, December 2017 - May 2018 24
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals and Deal Values (%), May 2018 26
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 27
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, December 2017 - May 2018 28
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 29
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 30
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 31
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), May 2018 32
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 33
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, December 2017 - May 2018 35
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), December 2017 - May 2018 37
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 38
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 39
Table 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 40
Table 26: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), May 2018 41
Table 27: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, December 2017 - May 2018 43
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), May 2018 45
Table 29: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, May 2018 45
Table 30: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, May 2018 46
Table 31: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, May 2018 46
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 48
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 51
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 54
Table 35: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 57
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 60
Table 37: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 63
Table 38: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 65
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 67
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 70
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 72
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 75
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 76
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 77

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 10
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), May 2018 14
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), May 2018 15
Figure 4: Pharmaceuticals & Healthcare, Global, M&As, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 16
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, December 2017 - May 2018 18
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 19
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 21
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 22
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, December 2017 - May 2018 24
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), May 2018 25
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), May 2018 26
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 27
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 29
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 30
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 31
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 33
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, December 2017 - May 2018 34
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, December 2017 - May 2018 35
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 36
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 38
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 39
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 40
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), December 2017 - May 2018 41
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, December 2017 - May 2018 42
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), December 2017 - May 2018 43
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), May 2018 44
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 47
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 50
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 53
Figure 30: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 56
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 59
Figure 32: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 62
Figure 33: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 64
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 66
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 69
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 71
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 74
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 76
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), December 2017 - May 2018 77

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *